This procedural ruling has no material impact on PTC's stock. The underlying litigation continues; monitor for substantive rulings on the merits or settlement developments.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jan 30 $156.13entry
- T+1 · 10mo ago +0.51%α +0.01% · $156.92
- T+5 · 9mo ago −0.26%α −0.07% · $155.72
- T+20 · 9mo ago +1.27%α +2.08% · $158.12
- T+60 · 7mo ago −12.18%α −15.31% · $137.11
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The court denied PTC Therapeutics' motion for leave to file a motion for reconsideration of the earlier order denying disqualification of opposing counsel. The ruling is a minor procedural setback with no material financial impact, as the underlying litigation continues.
Court Ruling Details
Key Facts
- Court denied PTC's motion for leave to file a motion for reconsideration of the November 26, 2025 order denying disqualification of Dr. Gladys Monroy and defendants' counsel.
- PTC argued the court failed to consider Delaware law regarding attorney-client privilege transfer, but the court found PTC did not raise this argument before the original order.
- The ruling is procedural and does not resolve the underlying litigation or impose any financial liability.
Financial Impact
Not specified
Risk Factors
- The underlying litigation remains unresolved, and PTC may face continued challenges regarding attorney-client privilege and disqualification issues.
- Further adverse rulings could increase litigation costs or create strategic disadvantages.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-31c41y4v-PTC |
Track record
18 reports on PTC
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +42.25% at T+20 after the Sep 11, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $196.22 Now $196.38 +0.08% settles Dec 15
- Nov 13, 20263d ago DEFM14A Mixed 7/10 Entry $196.60 Now $196.38 −0.11% settles Dec 15
- Nov 4, 202612d ago 8-K Neutral 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 6/10 Entry $194.60 Now $196.38 +0.91% settles Dec 4
- Nov 3, 202613d ago PREM14A Bullish 7/10 Entry $195.18 Now $196.38 +0.61% settles Dec 3
- Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $194.80 Now $196.38 +0.81% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $194.97 Now $196.38 +0.72% settles Nov 25
- Oct 19, 202628d ago Press Release Bullish 7/10 Entry $193.06 to $196.38 Now $196.38 +1.72% ▲ +1.72% +5.18% vs SPY
- Oct 5, 20266w ago DEFA14A Bullish 7/10 Entry $193.00 to $194.32 Now $196.38 +1.75% ▲ +0.68% +3.59% vs SPY
- Oct 5, 20266w ago DEFA14A Bullish 8/10 Entry $192.26 to $195.05 Now $196.38 +2.14% ▲ +1.45% +4.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers